| 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 |
| 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 | 1994 |


1996

  1. Bader O, Lui H. Laser safety and the eye: practical pearls and hidden hazards. American Academy of Dermatology, Washington, DC. February 1996.
  2. Bajdik CD, Gallagher RP, Astrakianakis G, Hilll GB, Fincham S, McLean DI. Non-solar ultraviolet radiation and the risk of basal and squamous cell skin cancer. [Short Communication] Brit J Cancer 1996:73;1612-1614.
  3. Berg D, Solish N, Kiene K, Lui H, Warshawski L, McLean D, Carruthers A. Use of topical 5-aminoleuvulinic acid for the preoperative assessment of non-melanoma skin cancers. Dermatologic Surg 1996 (in press).
  4. Bouwstra JA, Thewalt J, Gooris GS, Kitson N. A Model Membrane Approach to the Epidermal Permeability Banner: X-ray Diffraction Study. Biochemistry 1997;36: 7717-7725.
  5. Carruthers A, Kiene K, Caruthers J. Botulinum A exotoxin use in clinical dermatology. JAAD 1996;34:788-797.
  6. Chow R, Stewart WD, Ho VC. Graft-versus-Host reaction affecting lesional skin but not normal skin in a patient with piebaldism. Brit J Dermatol 1996;134:134-137.
  7. Chow RKP, Ho VC. The treatment of pyoderma gangrenosum: a review. J Amer Acad Dermatol 1996;34:1047-1060.
  8. Crawford RI, Lawlor ER, Wadsworth LD, Prendiville JS. Transient erythroporphyria of infancy. J Am Acad Dermatol 1996;35:8334.
  9. Dutz JP, Ho VC. Immunosuppressive agents in skin disorders: a comparative review. Clin Immunother 1996:5;268-293
  10. Dutz JP, Lupin M, Lui H. A comparative study of UVB/tar/calcipotriol and UVB/tar/anthralin in a day care setting for chronic plaque psoriasis. Photodermatol Photoimmunol Photomed 1996;12:37.
  11. Dutz JP, Lupin M, Lui H. A comparative study of UVB/calcipotriol and UVB/anthralin in a day care setting for chronic plaque psoriasis. Clinical Dermatology 2000 International Congress, Vancouver. 1996:173.
  12. Gallagher RP, Bajdik CD, Fincham S, Hill GB, Keefe AR, Coldman A, McLean DI. Chemical exposures, medical history and risk of squamous and basal cell carcinoma of the skin. Cancer Epidemiology Biomarkers & Prevention 1996:5;419-424.
  13. Gallagher RP, Hill GB, Bajdik CD, Fincham S, Keefe AR, Coldman A, McLean DI. Non-solar risk factors for squamous and basal cell carcinoma of the skin. Amer J Epidemiol (submitted)
  14. Gallagher RP, McLean DI, Carruthers JA. What proportion of basal cell carcinomas on sun exposed areas are preventable? First Joint Meeting of the Japanese and Canadian Societies for Investigative Dermatology. Whistler, Canada. May 1996.
  15. Hancock J, Rivers JK, McLean DI, Gallagher RP. Melanocytic nevus density in Canadian Native Indian Children. J Am Acad Dermatol 1996:34;517-519.
  16. Li G, Mitchell DL, Ho VC, Reed JC, Tron VA. Decreased DNA repair but normal apoptosis in UV-irradiated skin of p53 transgenic mice. Am J Path 1996:148;1113-1123.
  17. Lui H, Hruza L, McLean DI, Hruza G, Gelmon K, Kollias N, Wimberly J, Gagel M, Anderson RR. Photodynamic therapy of malignant skin tumors with BPD verteporfin (benzoporphyrin derivative). Clinical Dermatology 2000 International Congress, Vancouver, 1996:146.
  18. Lui H, Zeng H, MacAulay C, Palcic B, McLean D. Ratio analysis of reflectance and fluorescence spectra of diseased skin. 24th Annual Meeting, American Society for Photobiology. June 1996.
  19. Lui H, Zeng H, MacAulay C, Palcic B, McLean DI. Optical spectroscopy as a potential diagnostic aid for dermatology. Clinical Dermatology 2000 International Congress, Vancouver. 1996:176.
  20. Lui H, Zeng H, McLean DI, MacAulay CE, Palcic B. In vivo fluorescence spectroscopy monitoring of BPD veteporfin concentration changes in skin tissue during photodynamic therapy of skin cancer.
    J Dermatol Sci 1996;12:87.
  21. Lui H. Lasers 2000. Clinical Dermatology 2000 International Congress, Vancouver, 1996:103.
  22. Lui H. Pigmented lesion treatment with lasers. Clinical Dermatology 2000 International Congress, Vancouver, 1996:121.
  23. McCarthy WH, Shaw HM, McCarthy SW, Rivers JK, Thompson JF. Cutaneous melanomas that defy conventional prognostic indicators. Seminars in Oncology 1996:23(6); 709-713.
  24. McLean DI, Lui H. Paraneoplastic Syndromes. In: Arndt, K (ed) Cutaneous Medicine and Surgery. WB Saunders Co. 1996:1843-1852.
  25. McLean DI. Controversies in the use of sunscreens. Skin Cancer and UV Radiation, Ruhr University, Bochum, Germany. Melanoma Research 1996;6(1):S7.
  26. van der Meij EH, Epstein JB, Hay J, Ho V, Lerner K. Sweet's Syndrome in a Patient with Oral Cancer Associated with Radiotherapy. Oral Oncol, Eur J Cancer, Vol. 32B, No. 2, pp. 133-136, 1996.
  27. Mitchell JC and Maibach HI. Difficulties to Investigate Dermatitis from Plants: A practical approach to office-based diagnosis. Dermatosen / Occup. Environ. 1996;44:29-33.
  28. Rivers JK, Albrecht L, Tron V. Keratinocyte-derived tumors. In: Dover JS (Ed), Cutaneous Medicine and Surgery. An Integrated Program in dermatology. Self-Assessment and Review. WB Saunders Co. 1996;234-247.
  29. Rivers JK. Melanoma. Lancet 1996:347;803-806.
  30. Sapijaszko MJA, Brant R, Sandham D, Berthiaume Y. Nonrespiratory predictor of mechanical ventilation dependency in intensive care unit patients. Crit Care Med 1996; 24:601-607.
  31. Shapiro J, Lui H, Tron V,Ho V. Systemic cyclosporine and low dose prednison in the treatment of chronic severe alopecia areata: a clinical and immunopatHologic evaluation. Clinical Dermatology 2000 International Congress, Vancouver. 1996:173.
  32. Shapiro J, Lui H,Ho V. Systemic cyclosporine and low dose prednisone in the treatment of chronic severe alopecia areata: a clinical and immunopathologic evaluation. In: Hair Research for the Next Millenium. Van Neste DJJ, Randall VA, eds. Elsevier Science, Amsterdam. 1996:279-280.
  33. Shapiro J, Maddin S. Medicated shampoos. Clinics in Dermatology, 1996;14:123-128.
  34. Shapiro J. Diseases of the Hair. In: Conn's Current Therapy, 1996, pgs 739-741. Ed. Robert E. Rakel, W.B. Saunders Co.
  35. Shapiro J. Alopecia Areata - Understanding and Coping with Hair Loss. JohnHopkins Press, 1996.
  36. Trotter MJ, Crawford RI, O’Connell JX, Tron VA. Mitotic granuloma annulare: A clinicopathologic study of 20 cases. J Cutan Pathol 1996;23:537-545.
  37. van der Meij EH, Epstein JB, Hay J,Ho VC, Lerner K. Sweet's syndrome in a patient with oral cancer associated with radiotherapy. A case report. Oral Onc 1996 (in press).
  38. White WL, Panella MJ, Rivers JK,Hong-JX. The expression of the retinoblastoma gene product in malignant melanoma and its relationship to p53: an immunohistochemical study. J Cut Pathol, in press.
  39. Zeng H, Lui H, McLean DI, MacAulay C, Palcic B. Update on fluorescence spectroscopy studies of diseased skin. Proceedings from SPIE/International Society for Optical Engineering (BiOS'96), 1996; 2671:196-198.
  40. Zeng H, Lui H, McLean DI, MacAulay CE, Kelly B, Palcic B. Penetration depth of topical BPD verteporfin in rabbit skin determined by microspectrophotometer measurements. J Dermatol Sci 1996;12:86.
  41. Zuker RM, Sapijaszko M. Latex allergy in association with tissue expansion. Can J Plast Surg 1995;3(3):163-165.


« Back to Publications & Reports

05.19.09